Research is being conducted on the clinical spectrum of complete FBN1 allele deletions. The condition appears to be related to certain genetic disorders, including Marfan and Ehlers-Danlos syndromes. The use of chromosomal microarray analysis may have an impact on the clinical management of these conditions, although the specifics of this relationship are not clear.